View Document Preview and Link Document Date: 2011-04-11 12:32:29 Open Document File Size: 426,86 KB Share Result on Facebook
City Reference / / Company U.S. LLC / / Facility Laboratory Test Interactions / Laboratory Tests / Laboratory Tests Response / / IndustryTerm gray rubber cap / treatment of advanced prostate cancer / Monitor for cardiovascular disease / injection site / treatment for patients with prostate cancer / mixed product / / MedicalCondition injections5 Pruritis / ureteral obstruction / Tumor / paralysis / metastatic prostate cancer / advanced prostate cancer / pituitary apoplexy / disease / Gastroenteritis/colitis / sudden cardiac death / Skin Pruritis / Neither patient experienced erythema / Hypersensitivity ELIGARD / vertebral metastases / hematuria / Musculoskeletal Arthralgia / Carcinogenesis / Hyperglycemia / bladder outlet obstruction / cardiovascular disease / diabetes / Alopecia / Erythema / Known hypersensitivity / pain / fatigue / myocardial infarction / diabetes mellitus / spinal cord compression / Urinary frequency Nocturia Gastrointestinal Nausea / Anaphylactic reactions / Hypersensitivity / prostate cancer / Cardiovascular diseases / paresthesia / Diabetes Hyperglycemia / Gynecomastia / / MedicalTreatment Counseling / / Organization DOSAGE AND ADMINISTRATION / FDA / / / Product leuprolide acetate / testosterone / ELIGARD / / Technology Pharmacokinetics / diagnostic tests / Pharmacodynamics / flash / / URL www.fda.gov/medwatch / / SocialTag 
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ELIGARD safely and effectively. See full prescribing information for ELIGARD. ELIGARD (leuprolide acetate) suspensio